Good discussion re: the manipulations available on the pennies. I don't usually dabble in the OTCs but this case was too tempting and with the Susman involvement and the potential upside, well, had to get in.
I too would like to see another analysis by MarkmanRunup. In previous discussions of intrinsic value, correct me if I'm wrong, but I don't recall any value being assigned to the licensing revenues going forward if we win. Anybody remember it differently?
News 
Market Data 
Discover 
